This study used structural equation modelling (SEM) to investigate whether retinal vascular density (VD) is related to individual executive function (EF) performance in healthy older adults, with ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty ...

This rare genetic condition causes hyperflexible joints, fragile skin, and possibly other symptoms, depending on which of 13 ...

This apparent hostility only worsened when another large vessel, Canadian MineSweeper HMCS Chaleur, which was moored in the same area, sank in 2021. According to Willson, he received a “three ...

Focus Point #3 Hemifield defects occur in multiple sclerosis but are frequently asymptomatic and usually result from large lesions involving the optic radiations. Focus Point #4 Ocular ...

The cause of ocular migraine depends on the subtype. Retinal migraine is due to changes that affect the blood vessels that serve the eyes. Migraine with aura results from electrical activity ...

Eyestem Research, a Bangalore-based cell therapy company, announced significant vision improvement in phase 1 trials of its investigational drug product, Eyecyte-RPE, in patients with geographic ...

Avacincaptad pegol and pegcetacoplan have similar 12-month outcomes in slowing GA, with pegcetacoplan requiring fewer injections.